The Chlordiazepoxide Hydrochloride a, cataloged under National Stock Number 6505-00-074-4692, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Hoffmann-La Roche Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-00-074-4692 |
| Primary Part Number | NDC00140-0007-14 |
| Item Name | Chlordiazepoxide Hydrochloride a |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Hoffmann-La Roche Inc. |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 500.000 |
| Capsule Type | HARD |
| Capsule Content Form | POWDER |
| Active Medicament Medicinal Strength | 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00140-0007-14 PRIMARY | Hoffmann-La Roche Inc. (USA) |
| NDC00781-2580-05 | Sandoz Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00536-3490-05 | 5/9 Secondary reference Rugby Group Inc |
| LIBRAX | 5/1 Secondary reference Hoffmann-La Roche Inc. |
NSN 6505-00-074-4692 is a Chlordiazepoxide Hydrochloride a, manufactured by Hoffmann-La Roche Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-074-4692 has 2 manufacturer part numbers on file: NDC00140-0007-14 (Hoffmann-La Roche Inc.), NDC00781-2580-05 (Sandoz Inc.).
Key specifications for NDC00140-0007-14: Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 500.000; Capsule Type: HARD; Part Name Assigned by Controlling Agency: CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE CAPSULES 500 BOTTLE. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.